Live Breaking News & Updates on Anti Diarrheagenic Enterotoxigenic Escherichia

Stay updated with breaking news from Anti diarrheagenic enterotoxigenic escherichia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Immuron CEO Steven Lydeamore to present at Peak Sky High

MELBOURNE, Australia, May 31, 2024 Immuron Limited , an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will. ....

United States , Flagellin Sears , Steven Lydeamore , Immuron Platform Technology , Immuron Limited , Securities Exchange , Chief Executive Officer Steven Lydeamore , Peak Asset Management , Peak Sky High , Australian Register , Therapeutic Goods , Traveler Diarrhea , Opin Infect , Scandinavian Journal , Tropical Medicine , Immune Components , Anti Diarrheagenic Enterotoxigenic Escherichia , Hyperimmune Bovine Colostrum , Immuron News , Securities Act , Securities Exchange Act ,

Immuron Board Changes

MELBOURNE, Australia, May 31, 2024 Immuron Limited , an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his position as. ....

United States , United Kingdom , Roger Aston , Jeannie Joughin , Steven Lydeamore , Flagellin Sears , Paul Brennan , Securities Exchange , Bristol Myers Squibb , Immuron Limited , Immuron Platform Technology , Non Executive Director , Non Executive Chairman , Australian Register , Therapeutic Goods , Opin Infect , Scandinavian Journal , Tropical Medicine , Immune Components , Anti Diarrheagenic Enterotoxigenic Escherichia , Hyperimmune Bovine Colostrum , Immuron News , Securities Act , Securities Exchange Act ,

Immuron Board Changes - Immuron (NASDAQ:IMRN)

MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his ....

United Kingdom , United States , Jeannie Joughin , Steven Lydeamore , Flagellin Sears , Paul Brennan , Roger Aston , Securities Exchange , Bristol Myers Squibb , Immuron Limited , Immuron Platform Technology , Non Executive Director , Non Executive Chairman , Australian Register , Therapeutic Goods , Opin Infect , Scandinavian Journal , Tropical Medicine , Immune Components , Anti Diarrheagenic Enterotoxigenic Escherichia , Hyperimmune Bovine Colostrum , Immuron News , Securities Act , Securities Exchange Act ,

Immuron CEO Steven Lydeamore to present at Peak Sky High - Immuron (NASDAQ:IMRN)

MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer ....

United States , Flagellin Sears , Steven Lydeamore , Immuron Limited , Securities Exchange , Chief Executive Officer Steven Lydeamore , Peak Asset Management , Peak Sky High , Australian Register , Therapeutic Goods , Traveler Diarrhea , Opin Infect , Scandinavian Journal , Tropical Medicine , Immune Components , Anti Diarrheagenic Enterotoxigenic Escherichia , Hyperimmune Bovine Colostrum , Immuron News , Securities Act , Securities Exchange Act ,

Immuron Director Resignation

MELBOURNE, Australia, May 03, 2024 Immuron Limited , an Australian based and globally integrated biopharmaceutical company, advises that Stephen Anastasiou has resigned from his position as. ....

United States , Flagellin Sears , Stephen Anastasiou , Paul Brennan , Steven Lydeamore , Immuron Platform Technology , Securities Exchange , Immuron Limited , Non Executive Director , During Stephen , Chairman Paul Brennan , Australian Register , Therapeutic Goods , Traveler Diarrhea , Opin Infect , Scandinavian Journal , Tropical Medicine , Immune Components , Anti Diarrheagenic Enterotoxigenic Escherichia , Hyperimmune Bovine Colostrum , Immuron News , Securities Act , Securities Exchange Act ,